#compounded-medications

[ follow ]
#fda-enforcement #telehealth-platforms #glp-1-weight-loss-drugs #glp-1-drugs #fda-regulations #hims--hers
Public health
fromFortune
2 weeks ago

FDA warns Hims & Hers and other weight loss drugmakers to remove 'false and misleading' advertising | Fortune

FDA is targeting telehealth companies for promoting unofficial compounded versions of prescription drugs, warning against claims equating them to FDA-approved medications.
Health
fromInsideHook
3 months ago

Compounding Breaks Up Novo Nordisk-Hims & Hers Partnership

Compounded alternatives to GLP-1 drugs raise safety concerns and regulatory scrutiny.
[ Load more ]